Enzo Biochem, Inc. (NYSE:ENZ) Sees Significant Increase in Short Interest

Enzo Biochem, Inc. (NYSE:ENZ) saw a significant increase in short interest in the month of September. As of September 30th, there was short interest totalling 518,000 shares, an increase of 8.2% from the September 15th total of 478,700 shares. Based on an average trading volume of 74,600 shares, the days-to-cover ratio is presently 6.9 days. Approximately 1.4% of the company’s stock are sold short.

Institutional Trading of Enzo Biochem

An institutional investor recently raised its position in Enzo Biochem stock. Renaissance Technologies LLC increased its position in shares of Enzo Biochem, Inc. (NYSE:ENZ) by 2.6% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,499,546 shares of the medical research company’s stock after buying an additional 64,417 shares during the period. Renaissance Technologies LLC owned 4.86% of Enzo Biochem worth $2,725,000 as of its most recent filing with the SEC. 36.90% of the stock is owned by institutional investors.

Enzo Biochem Stock Up 0.9 %

Shares of Enzo Biochem stock traded up $0.01 during trading on Thursday, reaching $1.14. The company’s stock had a trading volume of 21,396 shares, compared to its average volume of 96,608. Enzo Biochem has a 1-year low of $0.99 and a 1-year high of $1.50. The company has a 50-day simple moving average of $1.12 and a two-hundred day simple moving average of $1.12.

Wall Street Analyst Weigh In

Separately, StockNews.com began coverage on shares of Enzo Biochem in a research note on Monday. They issued a “hold” rating for the company.

Enzo Biochem Company Profile

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.